Pathology consultation on influenza diagnostics

Allison R. McMullen, Neil W. Anderson, Carey Ann D. Burnhamfor

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Objectives: To describe the strengths and limitations of the available influenza diagnostics, with a focus on rapid antigen detection assays and nucleic acid detection assays. Methods: A case-based presentation is used to illustrate the potential limitations of rapid antigen detection assays for influenza. Results: Influenza is a seasonal illness; estimates attribute influenza to approximately 200,000 hospitalizations and 41,000 deaths in the United States annually. Antigen detection assays for influenza are rapid and convenient, and thus are widely used in a variety of health care settings, even though the sensitivity of these assays may be suboptimal. The United States Food and Drug Administration has recently created new guidelines intended to improve the oversight and performance characteristics of influenza antigen detection assays. Molecular assays, although more costly and complex, are more sensitive and may be designed to simultaneously detect multiple respiratory pathogens within a single assay. Conclusions: Diagnostic assays for influenza can vary greatly with regards to analytical performance characteristics, complexity, turnaround time and cost. This can have important patient care and infection prevention implications.

Original languageEnglish (US)
Pages (from-to)440-448
Number of pages9
JournalAmerican Journal of Clinical Pathology
Volume145
Issue number4
DOIs
StatePublished - Apr 1 2016

Fingerprint

Human Influenza
Referral and Consultation
Pathology
Antigens
United States Food and Drug Administration
Nucleic Acids
Patient Care
Hospitalization
Guidelines
Delivery of Health Care
Costs and Cost Analysis
Infection

Keywords

  • Diagnostics
  • Influenza
  • Nucleic acid amplification tests
  • Rapid influenza diagnostic test
  • Respiratory virus

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Pathology consultation on influenza diagnostics. / McMullen, Allison R.; Anderson, Neil W.; Burnhamfor, Carey Ann D.

In: American Journal of Clinical Pathology, Vol. 145, No. 4, 01.04.2016, p. 440-448.

Research output: Contribution to journalReview article

McMullen, Allison R. ; Anderson, Neil W. ; Burnhamfor, Carey Ann D. / Pathology consultation on influenza diagnostics. In: American Journal of Clinical Pathology. 2016 ; Vol. 145, No. 4. pp. 440-448.
@article{c7ec83bc2d074024899e3fc8b756220d,
title = "Pathology consultation on influenza diagnostics",
abstract = "Objectives: To describe the strengths and limitations of the available influenza diagnostics, with a focus on rapid antigen detection assays and nucleic acid detection assays. Methods: A case-based presentation is used to illustrate the potential limitations of rapid antigen detection assays for influenza. Results: Influenza is a seasonal illness; estimates attribute influenza to approximately 200,000 hospitalizations and 41,000 deaths in the United States annually. Antigen detection assays for influenza are rapid and convenient, and thus are widely used in a variety of health care settings, even though the sensitivity of these assays may be suboptimal. The United States Food and Drug Administration has recently created new guidelines intended to improve the oversight and performance characteristics of influenza antigen detection assays. Molecular assays, although more costly and complex, are more sensitive and may be designed to simultaneously detect multiple respiratory pathogens within a single assay. Conclusions: Diagnostic assays for influenza can vary greatly with regards to analytical performance characteristics, complexity, turnaround time and cost. This can have important patient care and infection prevention implications.",
keywords = "Diagnostics, Influenza, Nucleic acid amplification tests, Rapid influenza diagnostic test, Respiratory virus",
author = "McMullen, {Allison R.} and Anderson, {Neil W.} and Burnhamfor, {Carey Ann D.}",
year = "2016",
month = "4",
day = "1",
doi = "10.1093/AJCP/AQW039",
language = "English (US)",
volume = "145",
pages = "440--448",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "4",

}

TY - JOUR

T1 - Pathology consultation on influenza diagnostics

AU - McMullen, Allison R.

AU - Anderson, Neil W.

AU - Burnhamfor, Carey Ann D.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Objectives: To describe the strengths and limitations of the available influenza diagnostics, with a focus on rapid antigen detection assays and nucleic acid detection assays. Methods: A case-based presentation is used to illustrate the potential limitations of rapid antigen detection assays for influenza. Results: Influenza is a seasonal illness; estimates attribute influenza to approximately 200,000 hospitalizations and 41,000 deaths in the United States annually. Antigen detection assays for influenza are rapid and convenient, and thus are widely used in a variety of health care settings, even though the sensitivity of these assays may be suboptimal. The United States Food and Drug Administration has recently created new guidelines intended to improve the oversight and performance characteristics of influenza antigen detection assays. Molecular assays, although more costly and complex, are more sensitive and may be designed to simultaneously detect multiple respiratory pathogens within a single assay. Conclusions: Diagnostic assays for influenza can vary greatly with regards to analytical performance characteristics, complexity, turnaround time and cost. This can have important patient care and infection prevention implications.

AB - Objectives: To describe the strengths and limitations of the available influenza diagnostics, with a focus on rapid antigen detection assays and nucleic acid detection assays. Methods: A case-based presentation is used to illustrate the potential limitations of rapid antigen detection assays for influenza. Results: Influenza is a seasonal illness; estimates attribute influenza to approximately 200,000 hospitalizations and 41,000 deaths in the United States annually. Antigen detection assays for influenza are rapid and convenient, and thus are widely used in a variety of health care settings, even though the sensitivity of these assays may be suboptimal. The United States Food and Drug Administration has recently created new guidelines intended to improve the oversight and performance characteristics of influenza antigen detection assays. Molecular assays, although more costly and complex, are more sensitive and may be designed to simultaneously detect multiple respiratory pathogens within a single assay. Conclusions: Diagnostic assays for influenza can vary greatly with regards to analytical performance characteristics, complexity, turnaround time and cost. This can have important patient care and infection prevention implications.

KW - Diagnostics

KW - Influenza

KW - Nucleic acid amplification tests

KW - Rapid influenza diagnostic test

KW - Respiratory virus

UR - http://www.scopus.com/inward/record.url?scp=84981251925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981251925&partnerID=8YFLogxK

U2 - 10.1093/AJCP/AQW039

DO - 10.1093/AJCP/AQW039

M3 - Review article

C2 - 27124947

AN - SCOPUS:84981251925

VL - 145

SP - 440

EP - 448

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 4

ER -